What is the official ID of this bill?
The official print number for this legislation is S 2764.
Lowering Medicare Patient Costs for Negotiated Cancer and Complex Drugs.
This bill introduces a rebate system to lower out-of-pocket costs for Medicare Part B patients receiving certain expensive, negotiated drugs, often used for cancer and complex therapies. While Medicare initially pays the standard market rate, the patient's cost-sharing (coinsurance) is calculated based on the lower, negotiated maximum fair price, resulting in direct savings for beneficiaries. Drug manufacturers are required to rebate the price difference back to Medicare.
Key points
Reduces patient out-of-pocket costs (coinsurance) for selected high-cost drugs covered under Medicare Part B price negotiations.
Patient coinsurance is calculated using the lower, negotiated maximum price, rather than the higher average sales price.
Drug manufacturers must pay a rebate to Medicare equal to the difference between the standard payment rate and the negotiated rate.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.